Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10514921 | Journal of Clinical Epidemiology | 2005 | 5 Pages |
Abstract
First-time COX-2 inhibitor prescribing was somewhat dependent on patient factors in the first quarter of marketing, but the proportional influence of physician preferences increased substantially over the following 2 years, raising the question of why physician factors and not patient risk factors influence COX-2 inhibitor prescribing.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Sebastian Schneeweiss, Robert J. Glynn, Jerry Avorn, Daniel H. Solomon,